PMID- 24498166 OWN - NLM STAT- MEDLINE DCOM- 20141015 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 9 IP - 1 DP - 2014 TI - Milrinone relaxes pulmonary veins in guinea pigs and humans. PG - e87685 LID - 10.1371/journal.pone.0087685 [doi] LID - e87685 AB - INTRODUCTION: The phosphodiesterase-III inhibitor milrinone improves ventricular contractility, relaxes pulmonary arteries and reduces right ventricular afterload. Thus, it is used to treat heart failure and pulmonary hypertension (PH). However, its action on pulmonary veins (PVs) is not defined, although particularly PH due to left heart disease primarily affects the pulmonary venous bed. We examined milrinone-induced relaxation in PVs from guinea pigs (GPs) and humans. MATERIAL AND METHODS: Precision-cut lung slices (PCLS) were prepared from GPs or from patients undergoing lobectomy. Milrinone-induced relaxation was studied by videomicroscopy in naive PVs and in PVs pre-constricted with the ETA-receptor agonist BP0104. Baseline luminal area was defined as 100%. Intracellular cAMP was measured by ELISA and milrinone-induced changes of segmental vascular resistances were studied in the GP isolated perfused lung (IPL). RESULTS: In the IPL (GP), milrinone (10 microM) lowered the postcapillary resistance of pre-constricted vessels. In PCLS (GP), milrinone relaxed naive and pre-constricted PVs (120%) and this relaxation was attenuated by inhibition of protein kinase G (KT 5823), adenyl cyclase (SQ 22536) and protein kinase A (KT 5720), but not by inhibition of NO-synthesis (L-NAME). In addition, milrinone-induced relaxation was dependent on the activation of K ATP-, BK Ca (2+)- and Kv-channels. Human PVs also relaxed to milrinone (121%), however only if pre-constricted. DISCUSSION: Milrinone relaxes PVs from GPs and humans. In GPs, milrinone-induced relaxation is based on K ATP-, BK Ca (2+)- and Kv-channel-activation and on cAMP/PKA/PKG. The relaxant properties of milrinone on PVs lead to reduced postcapillary resistance and hydrostatic pressures. Hence they alleviate pulmonary edema and suggest beneficial effects of milrinone in PH due to left heart disease. FAU - Rieg, Annette D AU - Rieg AD AD - Institute of Pharmacology and Toxicology, Medical Faculty of Rhenish-Westphalian Technical University Aachen, Aachen, Germany ; Department of Anesthesiology, Medical Faculty of Rhenish-Westphalian Technical University Aachen, Aachen, Germany. FAU - Suleiman, Said AU - Suleiman S AD - Institute of Pharmacology and Toxicology, Medical Faculty of Rhenish-Westphalian Technical University Aachen, Aachen, Germany. FAU - Perez-Bouza, Alberto AU - Perez-Bouza A AD - Institute of Pathology, Medical Faculty of Rhenish-Westphalian Technical University Aachen, Aachen, Germany ; Institute of Pathology, Medical Faculty of Rhenish Friedrich-Wilhelms University Bonn, Bonn, Germany. FAU - Braunschweig, Till AU - Braunschweig T AD - Institute of Pathology, Medical Faculty of Rhenish-Westphalian Technical University Aachen, Aachen, Germany. FAU - Spillner, Jan W AU - Spillner JW AD - Department of Cardiac and Thorax Surgery, Medical Faculty of Rhenish-Westphalian Technical University Aachen, Aachen, Germany. FAU - Schroder, Thomas AU - Schroder T AD - Department of Surgery, Luisenhospital Aachen, Aachen, Germany. FAU - Verjans, Eva AU - Verjans E AD - Institute of Pharmacology and Toxicology, Medical Faculty of Rhenish-Westphalian Technical University Aachen, Aachen, Germany ; Department of Pediatrics, Medical Faculty of Rhenish-Westphalian Technical University Aachen, Aachen, Germany. FAU - Schalte, Gereon AU - Schalte G AD - Department of Anesthesiology, Medical Faculty of Rhenish-Westphalian Technical University Aachen, Aachen, Germany. FAU - Rossaint, Rolf AU - Rossaint R AD - Department of Anesthesiology, Medical Faculty of Rhenish-Westphalian Technical University Aachen, Aachen, Germany. FAU - Uhlig, Stefan AU - Uhlig S AD - Institute of Pharmacology and Toxicology, Medical Faculty of Rhenish-Westphalian Technical University Aachen, Aachen, Germany. FAU - Martin, Christian AU - Martin C AD - Institute of Pharmacology and Toxicology, Medical Faculty of Rhenish-Westphalian Technical University Aachen, Aachen, Germany. LA - eng PT - Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140131 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Large-Conductance Calcium-Activated Potassium Channels) RN - 0 (Phosphodiesterase 3 Inhibitors) RN - JU9YAX04C7 (Milrinone) SB - IM EIN - PLoS One. 2014;9(5):e97207 MH - Animals MH - Female MH - Guinea Pigs MH - Humans MH - Large-Conductance Calcium-Activated Potassium Channels/metabolism MH - Male MH - Milrinone/*pharmacology MH - Organ Culture Techniques MH - Phosphodiesterase 3 Inhibitors/*pharmacology MH - Pulmonary Edema/drug therapy/metabolism/pathology/physiopathology MH - Pulmonary Veins/metabolism/pathology/*physiopathology MH - Vascular Resistance/*drug effects MH - Vasodilation/*drug effects PMC - PMC3909212 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2014/02/06 06:00 MHDA- 2014/10/16 06:00 PMCR- 2014/01/31 CRDT- 2014/02/06 06:00 PHST- 2013/05/08 00:00 [received] PHST- 2014/01/01 00:00 [accepted] PHST- 2014/02/06 06:00 [entrez] PHST- 2014/02/06 06:00 [pubmed] PHST- 2014/10/16 06:00 [medline] PHST- 2014/01/31 00:00 [pmc-release] AID - PONE-D-13-18927 [pii] AID - 10.1371/journal.pone.0087685 [doi] PST - epublish SO - PLoS One. 2014 Jan 31;9(1):e87685. doi: 10.1371/journal.pone.0087685. eCollection 2014.